Abstract – Iliofemoral anatomy among Asians: Implications for transcatheter aortic valve implantation.

Iliofemoral anatomy among Asians: Implications for transcatheter aortic valve implantation.

Chiam Paul, Koh AS, Ewe SH, Sin YK, Chao VT, Ng CK, Lee CY, Lim YP, Su JW, Lim SL, Tan TE, Lim CH, Tan SY, Lim ST, Chua TS, Koh TH, Chua YL.  

International Journal of Cardiology 2013; 167: 1373-9

Abstract

BACKGROUND/OBJECTIVES:

This study aims to examine iliofemoral anatomy and predictors of vessel size and tortuosity in Asian patients as transfemoral transcatheter aortic valve implantation (TAVI) may be limited by the smaller Asian physique.

METHODS:

Characteristics and vessel dimensions of 549 patients undergoing ultrasonography were reviewed. The minimal luminal diameter (MLD) along the iliofemoral vasculature of each side was identified and the larger of the two sides was used to determine suitability for transfemoral TAVI.

RESULTS:

The mean age was 66 ± 11 years (68% males). Mean iliac MLD was 7.6 ± 1.7 mm, females smaller than males (7.2 ± 1.7 vs 7.8 ± 1.7, p<0.001). Mean iliac MLD decreased with age: 7.9 ± 1.7 mm, 7.4 ± 1.9 mm and 7.3 ± 1.6mm for ages <70 years, 70-79 years and ≥ 80 years respectively (p=0.038). Mean femoral MLD was 7.0 ± 1.7 mm, females smaller than males (6.3 ± 1.5mm vs 7.3 ± 1.8mm, p<0.001). Females were more likely than males to have iliac and femoral MLD <6mm (20% vs 12%, p=0.019 and 34% vs 21%, p=0.001). Independent predictors of smalleriliofemoral dimensions were female gender, lower body surface area, diabetes mellitus, dyslipidemia and smoking history. Significant iliac tortuosity was present in 11.8%, more frequent in males than females (15% vs 6%, p=0.005), and in those with logistic EuroSCORE ≥ 15 than <15 (27% vs 10%, p=0.001).

CONCLUSIONS:

This study establishes the mean iliac and femoral artery diameters in a cohort of relatively young Asian patients. Age and female gender were associated with smaller vessel dimension and several independent predictors of smaller vasculature and tortuosity were identified. These results have implications for TF TAVI in Asia.

Share:

More Posts

Diagram showing the components and placement of a Left Ventricular Assist Device (LVAD)

What Is an Artificial Heart Pump (LVAD) and Who Needs One?

For patients with advanced heart failure, medications alone may no longer be enough to help the heart pump blood effectively. A Left Ventricular Assist Device (LVAD), often referred to as an artificial heart pump, can help improve blood flow, relieve symptoms, and enhance quality of life. Learn how LVADs work, who may benefit from them, and what to expect before, during and after implantation.

Middle-aged Asian man clutching his chest, appearing to experience chest pain or symptoms of cardiac arrest.

Can Healthy Individuals Get Cardiac Arrest?

Even seemingly healthy individuals without known heart conditions can experience cardiac arrest. Recognising risk factors and adopting a heart-healthy lifestyle, including regular exercise, a balanced diet, avoiding smoking, limiting alcohol intake, managing stress and going for health screening regularly, can potentially reduce the risk.

Leaky tricuspid valve (tricuspid regurgitation) showing backward blood flow from the right ventricle into the right atrium

Minimally Invasive Treatment Options for Leaky Tricuspid Valve

A leaky tricuspid valve, also known as tricuspid regurgitation, is a heart valve condition that can cause swelling, breathlessness, fatigue, and worsening heart failure if left untreated. While open-heart surgery was once the only definitive treatment, advances in heart valve technology now allow selected patients to be treated using minimally invasive catheter-based procedures, including tricuspid transcatheter edge-to-edge repair, transcatheter tricuspid valve replacement, and caval valve implantation.

the connection between sleep problems and heart failure

The Hidden Connection between Sleep Problems and Heart Failure

Sleep problems are common among people with heart failure, and research shows the relationship goes both ways. Conditions such as obstructive sleep apnoea (OSA) and insomnia can worsen heart failure symptoms, while heart failure itself often leads to disturbed or poor-quality sleep. Recognising this two-way connection is an important step toward better symptom control and long-term heart health.

Privacy Settings
We use cookies to enhance your experience while using our website. If you are using our Services via a browser you can restrict, block or remove cookies through your web browser settings. We also use content and scripts from third parties that may use tracking technologies. You can selectively provide your consent below to allow such third party embeds. For complete information about the cookies we use, data we collect and how we process them, please check our Privacy Policy